The Lancet Diabetes & EndocrinologyVolume 10, Issue 2, February 2022, Pages 97-98CorrespondenceDapagliflozin in patients with COVID-19: mind the kidneysAuthor links open overlay panelThiago Reis a b, Marlies Ostermann c, Alexander Zarbock d, John A Kellum e, Claudio Ronco f gShow moreShareCitehttps://doi.org/10.1016/S2213-8587(21)00329-6Get rights and contentPrevious article in issueNext article in issueRecommended articlesCited by (0)View Abstract© 2021 Elsevier Ltd. All rights reserved.